Business Description
Zimmer Biomet Holdings Inc
NAICS : 339113
SIC : 3842
ISIN : US98956P1021
Compare
Compare
Traded in other countries / regions
ZBH.USAZBH.AustriaZIM.GermanyZBH.MexicoZ1BH34.BrazilZBH.Switzerland0QQD.UK IPO Date
2014-03-05Description
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.09 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.53 | |||||
| Debt-to-EBITDA | 2.97 | |||||
| Interest Coverage | 7.39 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.68 | |||||
| Beneish M-Score | -2.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6 | |||||
| 3-Year EBITDA Growth Rate | 29.7 | |||||
| 3-Year EPS without NRI Growth Rate | 10 | |||||
| 3-Year FCF Growth Rate | 2.8 | |||||
| 3-Year Book Growth Rate | 1.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 6.6 | |||||
| Future 3-5Y Total Revenue Growth Rate | 4.27 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.36 | |||||
| Quick Ratio | 0.7 | |||||
| Cash Ratio | 0.16 | |||||
| Days Inventory | 403.11 | |||||
| Days Sales Outstanding | 68.52 | |||||
| Days Payable | 60.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Payout Ratio | 0.12 | |||||
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | 5.47 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.78 | |||||
| Operating Margin % | 20.08 | |||||
| Net Margin % | 14.27 | |||||
| FCF Margin % | 16.44 | |||||
| ROE % | 8.64 | |||||
| ROA % | 5.04 | |||||
| ROIC % | 7.84 | |||||
| ROC (Joel Greenblatt) % | 27.73 | |||||
| ROCE % | 6.69 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.31 | |||||
| Forward PE Ratio | 18.01 | |||||
| PE Ratio without NRI | 13.54 | |||||
| Shiller PE Ratio | 34.54 | |||||
| Price-to-Owner-Earnings | 15.85 | |||||
| PEG Ratio | 1.56 | |||||
| PS Ratio | 2.9 | |||||
| PB Ratio | 1.72 | |||||
| Price-to-Free-Cash-Flow | 17.5 | |||||
| Price-to-Operating-Cash-Flow | 13.93 | |||||
| EV-to-EBIT | 22.04 | |||||
| EV-to-EBITDA | 12.34 | |||||
| EV-to-Revenue | 3.6 | |||||
| EV-to-FCF | 21.72 | |||||
| Price-to-Projected-FCF | 1.02 | |||||
| Price-to-Median-PS-Value | 0.84 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.12 | |||||
| Earnings Yield (Greenblatt) % | 4.54 | |||||
| FCF Yield % | 5.93 | |||||
| Forward Rate of Return (Yacktman) % | 17.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zimmer Biomet Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 6,637.763 | ||
| EPS (TTM) (CHF) | 4.581 | ||
| Beta | 0 | ||
| Volatility % | 0.26 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (CHF) | 0 | ||
| 20-Day SMA (CHF) | 136.12408 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (CHF) | 136.12408 - 136.12408 | ||
| Shares Outstanding (Mil) | 199.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zimmer Biomet Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zimmer Biomet Holdings Inc Stock Events
| Event | Date | Price(CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zimmer Biomet Holdings Inc Frequently Asked Questions
What is Zimmer Biomet Holdings Inc(LTS:0QQD)'s stock price today?
The current price of LTS:0QQD is CHF136.12. The 52 week high of LTS:0QQD is CHF136.12 and 52 week low is CHF136.12.
When is next earnings date of Zimmer Biomet Holdings Inc(LTS:0QQD)?
The next earnings date of Zimmer Biomet Holdings Inc(LTS:0QQD) is 2025-02-07 Est..
Does Zimmer Biomet Holdings Inc(LTS:0QQD) pay dividends? If so, how much?
Zimmer Biomet Holdings Inc(LTS:0QQD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers